Rapid increase in Omicron infections in England during December 2021: REACT-1 study.
Journal
Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511
Informations de publication
Date de publication:
25 03 2022
25 03 2022
Historique:
pubmed:
9
2
2022
medline:
6
4
2022
entrez:
8
2
2022
Statut:
ppublish
Résumé
The unprecedented rise in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections during December 2021 was concurrent with rapid spread of the Omicron variant in England and globally. We analyzed the prevalence of SARS-CoV-2 and its dynamics in England from the end of November to mid-December 2021 among almost 100,000 participants in the REACT-1 study. Prevalence was high with rapid growth nationally and particularly in London during December 2021, with an increasing proportion of infections due to Omicron. We observed large decreases in swab positivity among mostly vaccinated older children (12 to 17 years) relative to unvaccinated younger children (5 to 11 years), and in adults who received a third (booster) vaccine dose versus two doses. Our results reinforce the importance of vaccination and booster campaigns, although additional measures have been needed to control the rapid growth of the Omicron variant.
Identifiants
pubmed: 35133177
doi: 10.1126/science.abn8347
pmc: PMC8939772
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1406-1411Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19012
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Références
Wellcome Open Res. 2020 Aug 25;5:200
pubmed: 33997297
Science. 2021 May 28;372(6545):990-995
pubmed: 33893241
Genome Med. 2021 Feb 9;13(1):21
pubmed: 33563320
Science. 2021 Dec 17;374(6574):eabl9551
pubmed: 34726481
Lancet Respir Med. 2022 Apr;10(4):355-366
pubmed: 35085490
N Engl J Med. 2021 Dec 9;385(24):e84
pubmed: 34614326